Biotech · Public company · South San Francisco, CA, US
Cytokinetics Inc
Ticker CYTK · SEC CIK 0001061983
Track this companyFree. Adds Cytokinetics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials257 recruiting or active
Pipeline programs25From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline25
- AficamtenPhase 3 · Symptomatic Non-Obstructive Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- AficamtenPhase 3 · PediatricClinicalTrials.gov · fetched Nov 12, 2026
- Aficamten (5 - 20 mg)Phase 3 · Symptomatic Hypertrophic Cardiomyopathy (HCM)ClinicalTrials.gov · fetched Nov 12, 2026
- Aficamten (5 mg, 10 mg, 15 mg, and 20 mg)Phase 3 · Obstructive Hypertrophic Cardiomyopathy (oHCM)ClinicalTrials.gov · fetched Nov 12, 2026
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)Phase 3 · Obstructive Hypertrophic Cardiomyopathy (oHCM)ClinicalTrials.gov · fetched Nov 12, 2026
- Metoprolol succinate (50 mg, 100 mg, 150 mg and 200 mg)Phase 3 · Obstructive Hypertrophic Cardiomyopathy (oHCM)ClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv MecarbilPhase 3 · Heart Failure With Reduced Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv MecarbilPhase 3 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv Mecarbil (OM)Phase 3 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- ReldesemtivPhase 3 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- tirasemtivPhase 3 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
- CK-1827452Phase 2 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- CK-3773274 (10 - 30 mg)Phase 2 · Hypertrophic Cardiomyopathy (HCM)ClinicalTrials.gov · fetched Nov 12, 2026
- CK-3773274 (5 - 15 mg)Phase 2 · Hypertrophic Cardiomyopathy (HCM)ClinicalTrials.gov · fetched Nov 12, 2026
- CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)Phase 2 · Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)ClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv Mecarbil Matrix F1 FormulationPhase 2 · Modified Release Oral FormulationClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv Mecarbil Matrix F2 FormulationPhase 2 · Modified Release Oral FormulationClinicalTrials.gov · fetched Nov 12, 2026
- Omecamtiv Mecarbil Swellable Core Technology F2Phase 2 · Modified Release Oral FormulationClinicalTrials.gov · fetched Nov 12, 2026
- AficamtenPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- AMG 423Phase 1 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- CK-3773274 - Granules in CapsulePhase 1 · Symptomatic Obstructive Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- CK-3773274 - TabletsPhase 1 · Symptomatic Obstructive Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- CK-3828136Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- CK-4021586Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- HCMR Re-Imaging StudyRECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07054073 · fetched Nov 12, 2026
- Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic CardiomyopathyPHASE4 · RECRUITING · started May 5, 2026ClinicalTrials.gov NCT07600177 · fetched Nov 12, 2026
- AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPHASE2 · RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06793371 · fetched Nov 12, 2026
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPHASE3 · RECRUITING · started Dec 19, 2024ClinicalTrials.gov NCT06736574 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started May 29, 2024ClinicalTrials.gov NCT06412666 · fetched Nov 12, 2026
- A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 31, 2023ClinicalTrials.gov NCT06081894 · fetched Nov 12, 2026
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCMPHASE3 · COMPLETED · started Jun 20, 2023ClinicalTrials.gov NCT05767346 · fetched Nov 12, 2026
- Study to Evaluate the Effect of Aficamten Administration on QT/QTc IntervalPHASE1 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05924815 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started May 9, 2023ClinicalTrials.gov NCT05877053 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult ParticipantsPHASE1 · TERMINATED · started Dec 6, 2022ClinicalTrials.gov NCT05662215 · fetched Nov 12, 2026
- A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)PHASE3 · TERMINATED · started Aug 4, 2022ClinicalTrials.gov NCT05442775 · fetched Nov 12, 2026
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCMPHASE3 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05186818 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)PHASE3 · TERMINATED · started Aug 16, 2021ClinicalTrials.gov NCT04944784 · fetched Nov 12, 2026
- Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCMPHASE2_PHASE3 · ENROLLING_BY_INVITATION · started May 6, 2021ClinicalTrials.gov NCT04848506 · fetched Nov 12, 2026
- Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic CardiomyopathyPHASE2 · COMPLETED · started Jan 10, 2020ClinicalTrials.gov NCT04219826 · fetched Nov 12, 2026
- Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart FailurePHASE3 · COMPLETED · started Apr 9, 2019ClinicalTrials.gov NCT03759392 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult SubjectsPHASE1 · COMPLETED · started Dec 4, 2018ClinicalTrials.gov NCT03767855 · fetched Nov 12, 2026
- A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in MobilityPHASE1 · TERMINATED · started Jun 28, 2017ClinicalTrials.gov NCT03065959 · fetched Nov 12, 2026
- Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionPHASE3 · COMPLETED · started Jan 6, 2017ClinicalTrials.gov NCT02929329 · fetched Nov 12, 2026
- A Study for Patients Who Completed VITALITY-ALS (CY 4031)PHASE3 · COMPLETED · started Oct 17, 2016ClinicalTrials.gov NCT02936635 · fetched Nov 12, 2026
- A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary DiseasePHASE2 · COMPLETED · started Jun 30, 2016ClinicalTrials.gov NCT02662582 · fetched Nov 12, 2026
- COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart FailurePHASE2 · COMPLETED · started Feb 26, 2013ClinicalTrials.gov NCT01786512 · fetched Nov 12, 2026
- Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal InsufficiencyPHASE1 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01737866 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)PHASE2 · COMPLETED · started Apr 1, 2011ClinicalTrials.gov NCT01300013 · fetched Nov 12, 2026
- A Study of CK-1827452 Infusion in Stable Heart FailurePHASE2 · COMPLETED · started Apr 1, 2007ClinicalTrials.gov NCT00624442 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026